Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Current Medicinal Chemistry
|
September 25, 1999
Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases
F G Salituro, U A Germann, K P Wilson, et al.
Biochemistry
|
June 18, 1985
Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition
D H Rich, M S Bernatowicz, N S Agarwal, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 11, 2017
Breakthroughs in neuroactive steroid drug discovery
Maria-Jesus Blanco, Daniel La, Quinn Coughlin, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 24, 2000
The basal SAR of a novel insulin receptor activator
H B Wood, R Black, G Salituro, et al.
Mini Reviews in Medicinal Chemistry
|
March 23, 2004
Kinase chemogenomics: targeting the human kinome for target validation and drug discovery
E ter Haar, W P Walters, S Pazhanisamy, et al.
Epilepsy Research
|
May 19, 2017
Anticonvulsant profile of the neuroactive steroid, SGE-516, in animal models
Rebecca S Hammond, Alison L Althaus, Michael A Ackley, et al.
Plos One
|
June 4, 2015
Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease
Ronald W Irwin, Christine M Solinsky, Carlos M Loya, et al.
Journal of Medicinal Chemistry
|
May 15, 1992
3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site
F G Salituro, B L Harrison, B M Baron, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
April 1, 1996
Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domain
A J Bitonti, J A Dumont, F G Salituro, et al.
Journal of Neuroscience Methods
|
May 18, 2018
A new method for determining levels of sedation in dogs: A pilot study with propofol and a novel neuroactive steroid anesthetic
B L Youngblood, Y Ueyama, W W Muir, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Current Medicinal Chemistry
|
September 25, 1999
Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases
F G Salituro, U A Germann, K P Wilson, et al.
Biochemistry
|
June 18, 1985
Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition
D H Rich, M S Bernatowicz, N S Agarwal, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 11, 2017
Breakthroughs in neuroactive steroid drug discovery
Maria-Jesus Blanco, Daniel La, Quinn Coughlin, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 24, 2000
The basal SAR of a novel insulin receptor activator
H B Wood, R Black, G Salituro, et al.
Mini Reviews in Medicinal Chemistry
|
March 23, 2004
Kinase chemogenomics: targeting the human kinome for target validation and drug discovery
E ter Haar, W P Walters, S Pazhanisamy, et al.
Epilepsy Research
|
May 19, 2017
Anticonvulsant profile of the neuroactive steroid, SGE-516, in animal models
Rebecca S Hammond, Alison L Althaus, Michael A Ackley, et al.
Plos One
|
June 4, 2015
Allopregnanolone preclinical acute pharmacokinetic and pharmacodynamic studies to predict tolerability and efficacy for Alzheimer's disease
Ronald W Irwin, Christine M Solinsky, Carlos M Loya, et al.
Journal of Medicinal Chemistry
|
May 15, 1992
3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site
F G Salituro, B L Harrison, B M Baron, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
April 1, 1996
Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domain
A J Bitonti, J A Dumont, F G Salituro, et al.
Journal of Neuroscience Methods
|
May 18, 2018
A new method for determining levels of sedation in dogs: A pilot study with propofol and a novel neuroactive steroid anesthetic
B L Youngblood, Y Ueyama, W W Muir, et al.
Page
of 5